STOK vs ALVO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
STOK · Stoke Therapeutics$26.54 ▲ 1.80%
ALVO · Alvotech$4.86 ▲ 6.81%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- STOK +18.6%
- ALVO -11.3%
Head to head
| Metric | STOK | ALVO |
|---|---|---|
| Price | $26.54 | $4.86 |
| Change today | ▲ 1.80% | ▲ 6.81% |
| Market cap | $1.74B | $1.73B |
| Return, 3 months | -17.7% | +28.9% |
| Return, year to date | -16.4% | -5.3% |
| Return, 1 year | +16.1% | -14.9% |
| P/E (TTM) | -7.0 | -8.0 |
| P/B | 4.9 | -8.6 |
| P/E percentile vs own 5y | 24th | 24th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +5.9% | -38.9% |
| Net profit growth (YoY) | -92.0% | -308.6% |
| Gross margin | – | 60.4% |
| Operating margin | -913.2% | 9.7% |
| Net margin | -862.1% | -36.5% |
| Return on equity | -73.6% | – |
| Analyst target vs. price | +69.6% | +57.8% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 52 | 47 |
| 30-day volatility | 47.9% | 67.5% |
| Max drawdown, 1 year | -41.3% | -63.1% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- STOK is the largest of the group by market value.
- STOK has returned the most over the past year.
- ALVO carries the lowest trailing P/E.
- STOK is growing revenue fastest.
- ALVO keeps the most profit per dollar of sales.
- STOK has been the calmest stock over the last 30 days.